In the phase III IMmotion151 trial of metastatic renal cell carcinoma the easy-to-implement modified Glasgow prognostic score predicts outcome more accurately than the IMDC score.

Subjects

Subjects :

Clinical Trials, Phase III as Topic
Disease-Free Survival
Humans
Molecular Targeted Therapy
Prognosis
Retrospective Studies
Carcinoma, Renal Cell pathology
Kidney Neoplasms drug therapy
Kidney Neoplasms pathology

Details

Language :

English

ISSN :

1569-8041

Volume :

33

Issue :

9

Database :

MEDLINE

Journal :

Annals of oncology : official journal of the European Society for Medical Oncology

Publication Type :

Editorial & Opinion

Accession number :

35716906

Full Text :

https://doi.org/10.1016/j.annonc.2022.06.003